|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.07 USD | +4.79% |
|
-2.99% | +34.27% |
| Market Cap | 526M 457M 425M 392M 738M 50.26B 751M 5.03B 1.97B 24.96B 1.98B 1.93B 83.94B | P/E 2026 * |
-2.53x | P/E 2027 * | -2.98x |
|---|---|---|---|---|---|
| Enterprise Value | 299M 260M 241M 222M 419M 28.54B 426M 2.85B 1.12B 14.17B 1.12B 1.1B 47.67B | EV / Sales 2026 * |
25.8x | EV / Sales 2027 * | 18.5x |
| Free-Float |
96.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: 4D Molecular Therapeutics, Inc.
| 1 day | +4.79% | ||
| 1 week | -2.99% | ||
| Current month | -24.29% | ||
| 1 month | -24.29% | ||
| 3 months | +13.53% | ||
| 6 months | +13.66% | ||
| Current year | +34.27% |
| 1 week | 9.39 |  | 10.66 |
| 1 month | 9.39 | | 13.4 |
| Current year | 6.96 | | 14 |
| 1 year | 4.99 | | 14 |
| 3 years | 2.24 | | 36.25 |
| 5 years | 2.24 | | 36.25 |
| 10 years | 2.24 | | 55.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Theresa Janke
COO | Chief Operating Officer | 51 | 2018-03-31 |
David Kirn
CEO | Chief Executive Officer | 64 | 2013-09-11 |
| Chief Tech/Sci/R&D Officer | 64 | 2024-01-01 |
| Director | Title | Age | Since |
|---|---|---|---|
David Kirn
CHM | Chairman | 64 | 2013-09-11 |
Charles Theuer
BRD | Director/Board Member | 62 | 2015-11-30 |
Jacob Chacko
BRD | Director/Board Member | 47 | 2019-02-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/10/26 | Sell | Founder | -15,725 | 0.0301% | ||
| 6/30/26 | Fiscal year | Compliance Officer | 19,698 | 0.0377% | ||
| 6/17/26 | Free | Director | 50,000 | 0.0956% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.79% | -2.99% | +128.34% | -45.09% | 502M | |
| -0.80% | +5.16% | -0.70% | +13.00% | 48.95B | |
| -3.95% | +14.70% | +24.15% | +5.15% | 40.75B | |
| +6.22% | +1.81% | +419.17% | +647.45% | 38.46B | |
| -1.57% | -1.44% | +7.38% | +43.06% | 36.38B | |
| +5.56% | +11.70% | +11.64% | +51.50% | 28.45B | |
| -0.39% | -0.63% | - | - | 16.62B | |
| -1.13% | -4.54% | +32.10% | +126.95% | 16.33B | |
| -7.10% | -2.81% | -8.80% | -34.35% | 13.65B | |
| -0.06% | +3.75% | +3.81% | +10.08% | 13.56B | |
| Average | +0.16% | +4.22% | +68.57% | +90.86% | 25.36B | |
| Weighted average by Cap. | +0.08% | +7.16% | +76.75% | +128.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 11.6M 10.08M 9.36M 8.63M 16.25M 1.11B 16.55M 111M 43.37M 550M 43.56M 42.61M 1.85B | 17.51M 15.21M 14.12M 13.02M 24.53M 1.67B 24.98M 167M 65.46M 830M 65.75M 64.31M 2.79B |
| Net income | -277M -240M -223M -206M -388M -26.42B -395M -2.64B -1.03B -13.12B -1.04B -1.02B -44.13B | -282M -245M -227M -210M -395M -26.91B -402M -2.69B -1.05B -13.37B -1.06B -1.04B -44.95B |
| Net Debt | -227M -198M -183M -169M -319M -21.72B -325M -2.17B -850M -10.79B -854M -836M -36.27B | -203M -176M -164M -151M -284M -19.37B -289M -1.94B -759M -9.62B -762M -745M -32.35B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-30 | US$10.07 | +4.79% | 539,916 |
| 26-07-29 | US$9.610 | -2.44% | 529,947 |
| 26-07-28 | US$9.850 | -5.11% | 628,850 |
| 26-07-27 | US$10.38 | +3.08% | 531,419 |
| 26-07-24 | US$10.07 | -2.99% | 682,426 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FDMT Stock
Select your edition
All financial news and data tailored to specific country editions
